Amrize Ltd (NYSE:AMRZ) Given Average Rating of “Moderate Buy” by Analysts

Shares of Amrize Ltd (NYSE:AMRZGet Free Report) have earned a consensus rating of “Moderate Buy” from the fifteen analysts that are currently covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $60.75.

Several equities analysts have recently weighed in on the company. Oppenheimer lifted their price target on Amrize from $62.00 to $64.00 and gave the company an “outperform” rating in a research report on Thursday, January 15th. Weiss Ratings upgraded Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday. UBS Group lifted their target price on Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, January 8th. Morgan Stanley set a $61.00 price target on shares of Amrize and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Finally, Royal Bank Of Canada lowered shares of Amrize from an “outperform” rating to a “sector perform” rating and raised their price objective for the company from $56.00 to $60.00 in a research report on Monday, December 8th.

Read Our Latest Research Report on Amrize

Insider Buying and Selling

In other news, Director Nicholas C. Gangestad purchased 2,000 shares of Amrize stock in a transaction dated Wednesday, November 19th. The stock was purchased at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the transaction, the director directly owned 4,958 shares of the company’s stock, valued at approximately $234,711.72. This trade represents a 67.61% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.

Hedge Funds Weigh In On Amrize

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in shares of Amrize by 5.6% during the 4th quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company’s stock valued at $1,722,500,000 after buying an additional 1,676,843 shares in the last quarter. Norges Bank bought a new position in Amrize in the fourth quarter valued at $929,333,000. Dodge & Cox bought a new position in Amrize in the second quarter valued at $622,085,000. Wellington Management Group LLP raised its position in Amrize by 48.8% during the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after purchasing an additional 3,809,133 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Amrize by 1.6% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,674,921 shares of the company’s stock worth $532,076,000 after purchasing an additional 156,903 shares during the last quarter.

Amrize Stock Up 0.8%

AMRZ opened at $58.86 on Monday. Amrize has a 12 month low of $44.12 and a 12 month high of $60.57. The company has a market cap of $32.55 billion and a PE ratio of 31.99. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38. The company has a 50 day moving average of $55.38 and a 200 day moving average of $52.12.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.